Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease (Q41362341)

29 September 2017

Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

29 September 2017

1 reference

George Boon-Bee Goh

1

1 reference

29 September 2017

Mangesh R Pagadala

2

1 reference

29 September 2017

Jaividhya Dasarathy

3

1 reference

29 September 2017

Aynur Unalp-Arida

4

1 reference

29 September 2017

Rish K Pai

5

1 reference

29 September 2017

Lisa Yerian

6

1 reference

29 September 2017

Amer Khiyami

7

1 reference

29 September 2017

Achuthan Sourianarayanane

8

1 reference

29 September 2017

Ruth Sargent

9

1 reference

29 September 2017

Carol Hawkins

10

1 reference

29 September 2017

Srinivasan Dasarathy

11

1 reference

29 September 2017

Arthur J McCullough

12

1 reference

29 September 2017

24 February 2015

1 reference

Digestive Diseases and Sciences

29 September 2017

1 reference

29 September 2017

60

1 reference

29 September 2017

6

1 reference

29 September 2017

1825-1831

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-015-3529-8

29 September 2017

0 references

cites work

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Prevalence and associated metabolic factors of fatty liver disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Alanine aminotransferase decreases with age: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Liver physiology and liver diseases in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Diabetes and altered glucose metabolism with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, Am

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Non-alcoholic fatty liver disease in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3529-8

Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures

1 reference

12 December 2020

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly

1 reference

12 December 2020

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

1 reference

12 December 2020

10.1007/S10620-015-3529-8

Identifiers

DOI

1 reference

29 September 2017

1 reference